AI assistant
Sending…
ANI PHARMACEUTICALS INC — Director's Dealing 2015
Oct 14, 2015
31676_dirs_2015-10-14_545af692-aa50-4215-ade3-83a240dcc9d8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2015-10-12
Reporting Person: LANKAU PETER A (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-10-12 | Common Stock | A | 1500 | — | Acquired | 1500 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-10-12 | Stock Option | $40.52 | A | 3000 | Acquired | 2025-10-11 | Common Stock (3000) | Direct |
Footnotes
F1: Of the common stock granted to the Reporting Person, 750 shares vest on October 12, 2016 and the remaining 750 shares vest on October 12, 2017.
F2: Of the common stock granted to the Reporting Person, options to purchase 1,500 shares vest on October 12, 2016 and the remaining options to purchase 1,500 shares vest on October 12, 2017.
More from ANI PHARMACEUTICALS INC
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
May 8
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 4
Regulatory Filings
2026
Mar 3